These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34959892)

  • 1. Fatty Acid Metabolism and Derived-Mediators Distinctive of PPAR-α Activation in Obese Subjects Post Bariatric Surgery.
    Manca C; Pintus S; Murru E; Fantola G; Vincis M; Batetta B; Moroni E; Carta G; Banni S
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-α, on the management and prevention of obesity.
    Tutunchi H; Saghafi-Asl M; Ostadrahimi A
    Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):543-552. PubMed ID: 31868943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes.
    Tutunchi H; Ostadrahimi A; Saghafi-Asl M; Hosseinzadeh-Attar MJ; Shakeri A; Asghari-Jafarabadi M; Roshanravan N; Farrin N; Naemi M; Hasankhani M
    Pharmacol Res; 2020 Jun; 156():104770. PubMed ID: 32217148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha).
    Guzmán M; Lo Verme J; Fu J; Oveisi F; Blázquez C; Piomelli D
    J Biol Chem; 2004 Jul; 279(27):27849-54. PubMed ID: 15123613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between dietary oil treatments and genetic variants modulate fatty acid ethanolamides in plasma and body weight composition.
    Pu S; Eck P; Jenkins DJ; Connelly PW; Lamarche B; Kris-Etherton PM; West SG; Liu X; Jones PJ
    Br J Nutr; 2016 Mar; 115(6):1012-23. PubMed ID: 26806592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oea Signaling Pathways and the Metabolic Benefits of Vertical Sleeve Gastrectomy.
    Hutch CR; Trakimas DR; Roelofs K; Pressler J; Sorrell J; Cota D; Obici S; Sandoval DA
    Ann Surg; 2020 Mar; 271(3):509-518. PubMed ID: 30702457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion.
    Pettinelli P; Del Pozo T; Araya J; Rodrigo R; Araya AV; Smok G; Csendes A; Gutierrez L; Rojas J; Korn O; Maluenda F; Diaz JC; Rencoret G; Braghetto I; Castillo J; Poniachik J; Videla LA
    Biochim Biophys Acta; 2009 Nov; 1792(11):1080-6. PubMed ID: 19733654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism.
    Sun Y; Alexander SP; Garle MJ; Gibson CL; Hewitt K; Murphy SP; Kendall DA; Bennett AJ
    Br J Pharmacol; 2007 Nov; 152(5):734-43. PubMed ID: 17906680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The consumption of n-3 polyunsaturated fatty acids differentially modulates gene expression of peroxisome proliferator-activated receptor alpha and gamma and hypoxia-inducible factor 1 alpha in subcutaneous adipose tissue of obese adolescents.
    Mejía-Barradas CM; Del-Río-Navarro BE; Domínguez-López A; Campos-Rodríguez R; Martínez-Godínez Md; Rojas-Hernández S; Lara-Padilla E; Abarca-Rojano E; Miliar-García Á
    Endocrine; 2014 Feb; 45(1):98-105. PubMed ID: 23546614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.
    Fu J; Oveisi F; Gaetani S; Lin E; Piomelli D
    Neuropharmacology; 2005 Jun; 48(8):1147-53. PubMed ID: 15910890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partitioning of adipose lipid metabolism by altered expression and function of PPAR isoforms after bariatric surgery.
    Jahansouz C; Xu H; Hertzel AV; Kizy S; Steen KA; Foncea R; Serrot FJ; Kvalheim N; Luthra G; Ewing K; Leslie DB; Ikramuddin S; Bernlohr DA
    Int J Obes (Lond); 2018 Feb; 42(2):139-146. PubMed ID: 28894292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Dietary N-3 Polyunsaturated Fatty Acid Formulations Distinctively Modify Tissue Fatty Acid and N-Acylethanolamine Profiles.
    Murru E; Lopes PA; Carta G; Manca C; Abolghasemi A; Guil-Guerrero JL; Prates JAM; Banni S
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33671938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleic acid-derived oleoylethanolamide: A nutritional science perspective.
    Bowen KJ; Kris-Etherton PM; Shearer GC; West SG; Reddivari L; Jones PJH
    Prog Lipid Res; 2017 Jul; 67():1-15. PubMed ID: 28389247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary fatty acid profile influences circulating and tissue fatty acid ethanolamide concentrations in a tissue-specific manner in male Syrian hamsters.
    Sihag J; Jones PJH
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1563-1579. PubMed ID: 31301433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of plasma N-acylethanolamine levels and physiological parameters by dietary fatty acid composition in humans.
    Jones PJ; Lin L; Gillingham LG; Yang H; Omar JM
    J Lipid Res; 2014 Dec; 55(12):2655-64. PubMed ID: 25262934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dietary CLA on n-3 HUFA score and N-acylethanolamides biosynthesis in the liver of obese Zucker rats.
    Piras A; Carta G; Murru E; Lopes PA; Martins SV; Prates JA; Banni S
    Prostaglandins Leukot Essent Fatty Acids; 2015 Jul; 98():15-9. PubMed ID: 25912618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interplay between non-esterified fatty acids and bovine peroxisome proliferator-activated receptors: results of an
    Busato S; Bionaz M
    J Anim Sci Biotechnol; 2020; 11():91. PubMed ID: 32793344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Oleoylethanolamine Reduces Inflammatory Cytokines and Adhesion Molecules in TNF-α-induced Human Umbilical Vein Endothelial Cells by Activating CB2 and PPAR-α.
    Xu X; Guo H; Jing Z; Yang L; Chen C; Peng L; Wang X; Yan L; Ye R; Jin X; Wang Y
    J Cardiovasc Pharmacol; 2016 Oct; 68(4):280-291. PubMed ID: 27281236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal and fasting/refeeding-regulated tissue levels of endogenous PPAR-alpha ligands in Zucker rats.
    Izzo AA; Piscitelli F; Capasso R; Marini P; Cristino L; Petrosino S; Di Marzo V
    Obesity (Silver Spring); 2010 Jan; 18(1):55-62. PubMed ID: 19521349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats.
    Deblon N; Veyrat-Durebex C; Bourgoin L; Caillon A; Bussier AL; Petrosino S; Piscitelli F; Legros JJ; Geenen V; Foti M; Wahli W; Di Marzo V; Rohner-Jeanrenaud F
    PLoS One; 2011; 6(9):e25565. PubMed ID: 21980491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.